| Presented by: | The University of Nebraska Medical Center, Center for Continuing Education |
| Lecturer | Several lecturers |
| Approximate duration: | 1 hr. |
| Summary points: | In this text-based CME programme, an oncology expert summarises the initial findings of the Prostate Cancer Prevention Trial, and explains how finasteride may affect prostate cancer detection by prostate-specific antigen testing or digital rectal examination. |
| Accreditation: | The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The ACPE provider number is 447-000-08-423-H04-P.
Expiration date:: November 30, 2009. |
| Other: | Text-only CE. |
Finasteride and Prostate Cancer Prevention: The Latest Chapter
